We are live on ! Find out more
FCMI

Foresite Capital Management I Portfolio holdings

AUM $21.4M
1-Year Est. Return 80.48%
This Fund
S&P 500
This Quarter Est. Return
-40.52%
1 Year Est. Return
-80.48%
3 Year Est. Return
-40.72%
5 Year Est. Return
10 Year Est. Return
AUM
$33.9M
AUM Growth
-$23.3M
Cap. Flow
-$165K
Cap. Flow %
-0.49%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
EPZM
Epizyme, Inc
EPZM
+$165K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXG icon
1
10x Genomics
TXG
$5.55B
$33.9M 100%
750,000
EPZM
2
DELISTED
Epizyme, Inc
EPZM
-143,759
Closed -$165K

Similar funds

Foresite Capital Management I's Q2 2022 Portfolio in Review

As of Q2 2022, Foresite Capital Management I held 2 positions worth $33.9M, down 41% from $57.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management I's Q2 2022 filing shows 1 closed position. The largest sale was Epizyme, Inc, an estimated $165K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Foresite Capital Management I fully exited Epizyme, Inc in Q2 2022, selling an estimated $165K.
  • Foresite Capital Management I's ten largest holdings make up 100% of its $33.9M portfolio in Q2 2022.
  • Foresite Capital Management I opened 0 new positions and closed 1 in Q2 2022.
  • Foresite Capital Management I's portfolio value fell 41% quarter-over-quarter to $33.9M.

Based on Foresite Capital Management I's 13F filing for Q2 2022, filed 12 Aug 2022.